ArticleParasites & vectors2025
Population genetic diversity and natural Wolbachia infection in Aedes aegypti from Pakistan.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Publisher Correction: Population genetic diversity and natural Wolbachia infection in Aedes aegypti from Pakistan.Parasites & vectors · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAedes aegypti, the principal vector of dengue and other arboviruses, is widely distributed in Pakistan, yet its population genetics and endosymbiont status remain poorly characterized. This study aimed to investigate the genetic structure, haplotype diversity, and phylogeographic patterns of Ae. aegypti in dengue-endemic regions of Pakistan, and to screen for natural Wolbachia infections to provide baseline data for surveillance and vector control.
methodsOvitrap collections were conducted in 2021 across the provinces of Punjab (Bakkar) and Khyber Pakhtunkhwa (Charsadda, DI Khan, Kohat, and two sites within Peshawar: Hayat Abad and Tarnab). Following the morphological identification of adult Ae. aegypti, we extracted genomic DNA from confirmed specimens to amplify and sequence a 658-bp fragment of the mitochondrial cytochrome c oxidase I (COI) gene. Phylogenetic analyses, haplotype network construction, and population differentiation statistics were performed. Additionally, 300 field-caught adult mosquitoes were screened for Wolbachia using validated conventional and quantitative PCR assays targeting the Wolbachia surface protein (wsp) gene.
resultsPhylogenetic analysis of 166 COI sequences (92 from Pakistan) revealed a monophyletic Ae. aegypti clade with 99.65-100% sequence identity, with Pakistani isolates clustering with those from Saudi Arabia, Iran, and India. In total, 13 global haplotypes were identified, with Hap_3 dominating (53%) and shared across regions. Within Pakistan, eight haplotypes were detected, including region-specific variants, yielding high overall diversity (Hd 0.69; π = 0.007). District-level analysis showed that DI Khan and Bakkar had the highest haplotype diversity (Hd 0.73 and 0.71) but low nucleotide diversity (π = 0.005-0.006), whereas Kohat exhibited no haplotype diversity. Population structure was higher in Pakistan (FST 0.26; Nm 0.7) than globally (FST 0.17; Nm 1.19), consistent with low gene flow among Pakistani populations. No natural Wolbachia infections were detected in Ae. aegypti.
conclusionsAedes aegypti in Pakistan belong to a globally monophyletic lineage and show moderate mitochondrial diversity with higher population structure than the global population. The lack of detected Wolbachia infections suggests that natural strains are either absent or occur at very low prevalence. These findings provide a baseline for surveillance and support integrating Wolbachia-based biocontrol alongside conventional interventions in Pakistan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.